Sinovac's covid vaccine triggers quick immune response after Pfizer’s 90% efficacy

According to the preliminary trial results released on Wednesday, Sinovac Biotech’s experimental COVID-19 vaccine, CoronaVac, induced a quick immune response although its effectiveness cannot be determined as it is in the early to mid-stage clinical trials.

developing story ....